Serocvel XR (quetiapine) tablets with prolonged release 200 mg. №60

$167.70

Manufacturer: United

Purpose: Blocks dopamine and serotonin receptors, treats schizophrenia and bipolar disorder.

SKU: MED61239 Categories: ,

Description

Serocvel XR (quetiapine) tablets with prolonged release 200 mg. №60

Ingredients

Active ingredient: Quetiapine fumarate 200 mg.
Other ingredients: lactose monohydrate, microcrystalline cellulose, hypromellose, and more.

Dosage

Recommended dosage: The usual starting dose is 50 mg once daily, which can be gradually increased. Consult a healthcare professional for personalized dosing.

Indications

Serocvel XR tablets are indicated for the treatment of schizophrenia and bipolar disorder.

Contraindications

Do not use Serocvel XR if you are allergic to quetiapine or any other ingredients in the product. Consult your doctor for alternatives.

Directions

Take Serocvel XR tablets orally with or without food as directed by your healthcare provider. Do not crush or chew the tablets.

Scientific Evidence

Quetiapine, the active ingredient in Serocvel XR, has been extensively studied for its efficacy in treating schizophrenia and bipolar disorder. Research published in the Journal of Clinical Psychopharmacology demonstrated the superior efficacy of quetiapine in managing acute bipolar mania compared to placebo.

Additional Information

It is important to follow your healthcare provider’s instructions when taking Serocvel XR. Monitor for any unusual changes in mood, behavior, or thoughts while using this medication. Contact your doctor immediately if you experience any concerning symptoms.

Pharmacological Effects: Quetiapine works by blocking the action of certain neurotransmitters in the brain, such as dopamine and serotonin. This helps to regulate mood and behavior in patients with schizophrenia and bipolar disorder.

Clinical Trials: Clinical trials have shown that Serocvel XR is effective in reducing symptoms of schizophrenia and bipolar disorder, with a favorable side effect profile. Patients experienced significant improvements in their condition compared to placebo groups.